Sen. Chris Murphy and Rep. Rosa DeLauro are among lawmakers leading efforts to see whether the virus will harm supply.
DeLauro is tasked with enforcement of protections for workers and others; Larson will handle environmental concerns.
A bill designed to help Connecticut officials peer into the black box of drug pricing won final approval from a unanimous state Senate early Wednesday, and will now go to the governor. Proponents of the measure called it a necessary first step toward curbing expensive prescription drug prices.
WASHINGTON – Sen. Chris Murphy will introduce Scott Gottlieb, a Westport resident and candidate to head the Food and Drug Administration, to fellow members of the Senate panel that’s key to his confirmation – but that won’t keep the nominee from having a bit of a rough ride among Democrats.
WASHINGTON – The president’s spokesman says Trump still favors a plan to negotiate Medicare prices, but he did not mention it after a recent meeting with pharmaceutical executives, and his plans to speed FDA approval of new drugs may be hampered by his restrictions on new regulations and cuts to the federal workforce.
WASHINGTON – Connecticut, one of 11 states that approved a law requiring schools to stock EpiPens, is on drug maker Mylan’s sizable lobbying list. According to the center, Mylan, under fire for its steep price hikes of the EpiPen, expanded its lobbying presence in state houses to Connecticut and 35 additional states between 2010 to 2014.
WASHINGTON — Like other lawmakers who are now calling for an investigation of the massive price hikes in price hikes of EpiPens, Sen. Richard Blumenthal backed legislation that encouraged schools to stock the auto injector that delivers a drug that counters the effects of a fatal allergic reaction.
WASHINGTON – News that the United States and 11 other Pacific Rim nations had finally reached agreement on a new trade deal was not good for opponents of the pact like Rep. Rosa DeLauro, yet liberals have won a few small victories in the deal.
The state employee health plan has tailored its design to encourage people to manage chronic conditions, get preventive care and avoid emergency room visits. But costs are being driven up by the rising expense of specialty drugs for conditions including Hepatitis C, multiple sclerosis and cancer. It’s a challenge that’s not unique to the state employee health plans, health care experts said Tuesday.
WASHINGTON – As negotiators for a massive Pacific Rim trade pact meet in Maui for a final round of talks, Connecticut lawmakers are pressing for changes they say will keep the price of key medicines affordable for patients who need them overseas and in the United States.